President Barack Obama has named Vanderbilt researcher Christopher J. Lemons among the recipients of the Presidential Early Career Awards for Scientists and Engineers. It is the highest honor bestowed by the United States government on science and engineering professionals in the early stages of their independent research careers.

An inability to recognize faces may be an important mechanism underlying social inhibition and may contribute to, or maintain, social anxiety.

Combining therapies for melanoma that induce cell senescence and that activate the immune response may improve outcomes for patients.

Because donor organs are scarce, understanding the mortality risk associated with heart transplantation is an important consideration when evaluating patients for transplant.

Vanderbilt University Medical Center nephrologist and Associate Professor of Medicine Dr. William Fissell IV is making major progress on a first-of-its kind device to free kidney patients from dialysis. He is building an artificial implantable kidney with microchip filters and living kidney cells that will be powered by a patient’s own heart.

One small chemical change to an existing antibacterial drug results in a compound that is more effective against its target enzyme in tuberculosis, Vanderbilt researchers have discovered.

A protein that suppresses a key cancer pathway in the colon may be a potential biomarker for colitis-associated tumors, researchers at Vanderbilt University Medical Center reported last month in the journal Gut.